The Market Size of the artificial insemination sector, while a sub-component of the broader Assisted Reproductive Technology (ART) industry in South Korea, represents a massive and continuously expanding economic opportunity. Driven by the national imperative to counteract the world's lowest fertility rate, the total ART market was valued at approximately USD 693.0 million in 2024 and is projected to reach over USD 1.2 billion by 2033. Artificial insemination, particularly IUI, constitutes a substantial portion of this valuation, primarily through the sheer volume of cycles performed annually, with tens of thousands of procedures recorded each year. While the unit cost of an IUI cycle is significantly lower than that of IVF, the cumulative cost of repeated cycles, coupled with the mandatory use of specialized medical consumables, reagents, and hormonal medications, aggregates to a significant market value. The economic scale of the market is artificially inflated, but solidly underpinned, by massive public spending through the national health insurance system and local government subsidies.

This direct injection of public funds acts as a foundational revenue stream for clinics and device manufacturers alike, providing stability rarely seen in healthcare sectors dependent solely on private payment or co-pays. The true economic size encompasses not just the procedural fees, but the entire value chain, including manufacturers of IUI catheters, centrifuges for sperm preparation, and pharmaceutical companies providing ovarian stimulation drugs. Furthermore, the total Market Size is likely understated if one does not account for the indirect economic activity generated, such as the development of specialized laboratory infrastructure, training for reproductive professionals, and the increasing demand for fertility-related genetic screening services. Any serious evaluation of the South Korea Artificial Insemination Market Size must therefore synthesize data on patient volume, government reimbursement rates, and the value of the supporting supply chain to capture the full scope of this demographically critical industry.